[The neuroprotective properties of sex steroids and neurosteroids].
BACKGROUND
The nervous system is a target for steroid hormones as well as a steroidogenic tissue, and it produces steroids that have a paracrine or autocrine effect on neurons and glial cells. Steroids formed in nervous tissue are called neurosteroids in order to differentiate them, in terms of their origin, from the peripheral steroids, although they both share the same molecular structure.


METHODS
We analyse the capacity of neurons and glial cells to synthesise steroids and describe the role played in steroidogenesis by certain key molecules, such as steroidogenic acute regulatory protein, peripheral benzodiazepine receptor and aromatase enzyme, which acts as a catalyst in the conversion of testosterone into estradiol. We also provide a description of the different mechanisms of action of the hormonal steroids and neurosteroids in the nervous system. These include both the regulation of protein synthesis by neurons and glial cells, by acting on nuclear receptors, and rapid effects mediated by membrane receptors or the allosteric modulation of neurotransmitter receptors. We review the clinical and experimental evidence for the neuroprotective effects of sex steroids and neurosteroids, and the limitations of hormone replacement therapy following menopause.


CONCLUSIONS
Given the restraints involved in the systemic use of hormones as neuroprotective therapy, alternative strategies that take advantage of the neuroprotective properties of steroids must be sought. These could involve locally increasing their synthesis inside the brain or developing molecules that activate the steroid receptors in the nervous system and not in the peripheral organs.
Veiga
S
S
Instituto Cajal, CSIC, 28002 Madrid, Spain.
García-Segura
L M
LM
Azcoitia
I
I
D000818:Animals; D012739:Gonadal Steroid Hormones / Q000378:metabolism* / Q000627:therapeutic use; D006728:Hormones / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D015394:Molecular Structure; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D009424:Nervous System Physiological Phenomena; D009457:Neuroglia / Q000737:chemistry / Q000378:metabolism; D009474:Neurons / Q000737:chemistry / Q000378:metabolism; D018696:Neuroprotective Agents / Q000378:metabolism* / Q000627:therapeutic use
D012739:Gonadal Steroid Hormones; D006728:Hormones; D018696:Neuroprotective Agents